$VKTX

Viking Therapeutics, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA

VKTX chart

What traders are saying about $VKTX

Latest posts

Viking Therapeutics, Inc. news

Viking Therapeutics, Inc. key financials

USD2025202420232022
Revenue$0$0$0$0
Net income-$359.6M-$110.0M-$85.9M-$68.9M
Diluted EPS$-3.19$-1.01$-0.91$-0.90
Total assets (year end)$715.7M$908.3M$368.5M$168.5M
Cash and equivalents (year end)$165.8M$26.7M$55.5M$36.6M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Viking Therapeutics, Inc.

Ticker
VKTX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1607678

Frequently asked questions

What exchange is Viking Therapeutics, Inc. listed on?

Viking Therapeutics, Inc. trades on the Nasdaq under the ticker symbol VKTX.

What industry is Viking Therapeutics, Inc. in?

Viking Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Viking Therapeutics, Inc. headquartered?

Viking Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.

When does Viking Therapeutics, Inc.'s fiscal year end?

Viking Therapeutics, Inc.'s fiscal year ends on December 31.

How much revenue did Viking Therapeutics, Inc. report?

Viking Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.